Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes immunoassays, molecular, virology, and specialty products. Immunoassay tests are for physician offices, hospital laboratories, emergency departments, pharmacies, and other urgent care or alternative site settings. Molecular diagnostics cover laboratory and other segments. Virology portfolio involves direct fluorescent assays and culture-based tests for clinical virology laboratory. Specialty products serve bone health, autoimmune, and complement research communities. The company was founded in 1979 and is headquartered in San Diego, CA.
Call trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.